2019 - 2020 LEGISLATURE
June 6, 2019 - Introduced by Representatives Sinicki, Crowley, Hebl,
Ohnstad, Rodriguez, Shankland, Skowronski, Spreitzer, Subeck, C. Taylor
and Zamarripa, cosponsored by Senators Larson,
Ringhand and Wirch.
Referred to Committee on Rules.
1Relating to: designating June 2019 as Myasthenia Gravis Awareness Month.
Whereas, myasthenia gravis (MG) is an autoimmune neuromuscular disease 3
that causes chronic weakness, in which antibodies attack receptors in the body and 4
prevent muscle contraction; and
Whereas, MG frequently weakens muscles that control eye movement, facial 6
expressions, and swallowing, and its symptoms may include blurred vision, speech 7
impairment, difficulty chewing, shortness of breath, an unstable gait, and a 8
weakened grip; and
Whereas, a diagnosis of MG may be missed or delayed because it shares 10
symptoms in common with many other disorders; and
Whereas, in some cases, MG symptoms can worsen to the point of disability, 12
grave illness, or death, if there are gaps in or an absence of the several crucial health 13
care treatments that can enable those who endure MG to lead productive, active lives 14
of normal longevity; and
Whereas, MG is found most commonly in adult women under 40 and men over 2
60, but is not specific to either gender or any particular ethnic background; and
Whereas, MG is nonhereditary and noncontagious; and
Whereas, 10 to 20 out of every 100,000 Americans are diagnosed with MG, and 5
support groups exist in Wisconsin for those people; now, therefore, be it
6Resolved by the
assembly, the senate concurring, That
June 2019 is 7
hereby designated Myasthenia Gravis Awareness Month in Wisconsin.